Michael J. Fossler
International Drug Development(FR)Cytel (United States)(US)
Publications by Year
Research Areas
Pharmaceutical studies and practices, Receptor Mechanisms and Signaling, Statistical Methods in Clinical Trials, Pharmacogenetics and Drug Metabolism, Anesthesia and Sedative Agents
Most-Cited Works
- → Effects of the Novel Long-Acting GLP-1 Agonist, Albiglutide, on Cardiac Function, Cardiac Metabolism, and Exercise Capacity in Patients With Chronic Heart Failure and Reduced Ejection Fraction(2016)166 cited
- → The effects of 4‐aminopyridine in multiple sclerosis patients(1994)154 cited
- → A randomized, Phase IIb study investigating oliceridine (TRV130), a novel µ-receptor G-protein pathway selective (µ-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty(2017)144 cited
- → Pharmacometrics: A Multidisciplinary Field to Facilitate Critical Thinking in Drug Development and Translational Research Settings(2008)125 cited
- → A Report from the Pediatric Formulations Task Force: Perspectives on the State of Child-Friendly Oral Dosage Forms(2013)112 cited
- → Dosing in Heavy-weight/Obese Patients with the LMWH, Tinzaparin: A Pharmacodynamic Study(2002)101 cited